225 Results
News Briefs and Worth Repeating
Funding News Edition: February 21, 2024
Simplified Review Criteria Will Receive a Soft Launch; Provide Input on HIV Research Priorities Before March 28, 2024; Attend Virtual Seminar on Opportunities for Early-Career Researchers; NIH Has a YouTube Channel for Grants Policy Discussions
Understand Clinical Trials to Choose the Right Funding Opportunity
Funding News Edition: February 21, 2024
NIH defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.
“Has the Supreme Court’s ruling on affirmative action in college admissions changed NIH’s funding approach and priorities?”
Funding News Edition: February 21, 2024
“Is my National Research Service Award individual fellowship stipend considered taxable salary?”
Funding News Edition: February 21, 2024
NIAID Uses Selective Pay, Bridge Awards to Complement Top-Scoring Applications
Funding News Edition: February 7, 2024
NIAID strives to always fund those applications that score best in peer review, but we also discern which applications outside the payline can help guard against scientific gaps emerging in our research portfolio.
Take Note of Reissued Investigator-Initiated Clinical Trial NOFOs
Funding News Edition: February 7, 2024
The NIAID Clinical Trial Implementation Cooperative Agreement notice of funding opportunity (NOFO) is designed for high-risk trials. The NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement NOFO allows small business concerns to proposed investigator-initiated clinical trials.
Funding to Engage in Bioethical Research and Capacity Building Efforts
Funding News Edition: February 7, 2024
Focus on ethical, legal, and social implications (ELSI) research relevant to NIAID’s scientific mission: HIV/AIDS or its comorbidities; infectious diseases; organ transplantation; and ELSI of clinical trials and implementation science.
NIAID Seeks Dosimetry Verification Services to Harmonize Radiation Research Projects
Funding News Edition: February 7, 2024
Our Radiation and Nuclear Countermeasures Program seeks a contractor who can provide services and capabilities to maintain and expand a centralized dosimetry harmonization effort.
December 2023 ACD Meeting—UNITE, RADx, and Postdoctoral Training
Funding News Edition: February 7, 2024
NIH’s Advisory Committee to the Director (ACD) members provide recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.
Before You Apply, Find Instruction on NIH’s DMS Policy
Funding News Edition: February 7, 2024
NIH's Data Management and Sharing (DMS) Policy requires sharing of all scientific data, defined as all data necessary to replicate research findings regardless of whether the data are used to support scientific papers.
News Briefs and Worth Repeating
Funding News Edition: February 7, 2024
NIAID Is Operating Under a Continuing Resolution; Bookmark Helpful NIH SEED Resources for Small Businesses; Prepare Now for Opportunity on Cell and Gene Therapies for HIV Cure; Watch Webinar to Hone Applications for DEIA Supplements
Know What Application and Progress Report Information NIH May Share
Funding News Edition: February 7, 2024
Any recipient of federal support and the information they submit to the government is subject to the Freedom of Information Act (FOIA).
“When will I know the study section to which my application was assigned?”
Funding News Edition: February 7, 2024
New Bat Immunology Network Will Support Immune Mechanism Studies
Funding News Edition: January 17, 2024
NIAID aims to better understand the mechanisms by which bats regulate immune responses to clear infection and prevent or resolve excessive inflammation.
Apply to Research Initiative to Enhance Vaccine and Antibiotic Allergy Research
Funding News Edition: January 17, 2024
Conduct an innovative project to study the mechanisms and management of vaccine or antibiotic drug allergy, including research on allergic responses to anti-viral, anti-fungal, and anti-parasitic drugs.
Big Opportunity to Join Centers for Excellence in Translational Research
Funding News Edition: January 17, 2024
NIAID seeks applications from single institutions or consortia of institutions ready to generate, validate, and advance medical countermeasures against a select list of bacteria or fungi with known or emerging resistance to current therapies.
Comment on NIH-Wide Strategic Plan for Autoimmune Disease Research
Funding News Edition: January 17, 2024
Establishing an NIH-wide strategic plan will help the new Office of Autoimmune Disease Research create opportunities for synergistic innovation and implement cross-cutting research.
Consider Collaborating in U.S.-Finland Biomedical and Behavioral Research
Funding News Edition: January 17, 2024
U.S. institutions can submit investigator-initiated grant applications and, if selected for funding, the Research Council of Finland may fully fund the Finnish investigators.
Early-Stage Investigators Can Get Support for Innovative Pivots
Funding News Edition: January 17, 2024
The initiative is designed for early-stage investigators who want to initiate a research project in an area different from their previous research focus or training experience, and therefore have not produced preliminary data.
News Briefs and Worth Repeating
Funding News Edition: January 17, 2024
Tune in for NIAID Advisory Council Meeting on January 30, 2024; Attend NIH Office of Extramural Research Webinar on Grants Policy Changes; eRA Commons ID Required for Senior/Key Personnel, Other Significant Contributors; Offer Feedback on the NIH Strategic Plan for Data Science
For Prior Approval Requests, “Other” Does Not Mean Everything Else
Funding News Edition: January 17, 2024
Within eRA’s Prior Approval Module, a variety of templates exist to facilitate the most common request types: carryover, change of investigator, no-cost extension, big grants, and withdrawal.
“Is SARS-CoV-2 considered a select agent?”
Funding News Edition: January 17, 2024
SARS-associated coronavirus (SARS-CoV) and SARS-CoV/SARS-CoV-2 chimeric viruses resulting from any deliberate manipulation of SARS-CoV-2 to incorporate nucleic acids coding for SARS-CoV virulence factors are select agents.
“Does NIAID establish my organization’s F&A costs rate?”
Funding News Edition: January 17, 2024
Once a federally-funded rate is negotiated and established, it applies to all government funding agencies that support your recipient institution.
Know Your Timeline to Award If All Goes According to Plan
Funding News Edition: January 17, 2024
Knowing when NIAID will begin funding your project is essential—it’s necessary for hiring support staff or arranging subcontracts or even timing a renewal application.
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.